Global Foot and Mouth Disease Vaccine Market Forecast 2026–2035 Highlighting Growth Opportunities

April 8, 2026April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Anthrax Vaccine Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The foot and mouth disease vaccine market size has experienced robust growth in recent years. Projections indicate a rise from $2.83 billion in 2025 to $3.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this expansion can be linked to several factors, including the frequent occurrence of foot-and-mouth disease outbreaks, a growing livestock population, the implementation of government-sponsored vaccination initiatives, continuous improvements in traditional vaccine technologies, and an increased focus on animal health management.

The foot and mouth disease vaccine market is projected for significant expansion over the coming years. It is anticipated to reach $4.57 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This projected growth during the forecast period is primarily driven by factors such as the creation of rapid response and diva vaccines, broader multi-species vaccination efforts, the utilization of oil-adjuvanted and aluminum hydroxide-based vaccines, increased government financing for FMD control, and growing investments in cold chain and distribution systems. Key developments expected during this period involve a greater embrace of emergency vaccines for quick outbreak containment, an intensified focus on multi-species fmd vaccination initiatives, the progress of diva (differentiating infected from vaccinated animals) vaccines, expanded government-sponsored immunization drives, and the increasing application of oil-adjuvanted and aluminum hydroxide-based vaccines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8522&type=smp

What Major Drivers Are Influencing Demand In The Anthrax Vaccine Market?

The expansion of the livestock population is a key factor propelling the foot and mouth disease vaccine market. These animals, such as cows, horses, and pigs, are farm animals kept, raised, and used by humans. The livestock population is increasing due to a heightened demand for products derived from animals. A larger livestock population raises the likelihood of foot and mouth disease outbreaks, which in turn fuels market expansion. For example, the FAO, a US-based United Nations agency, reported in July 2023 that global milk output in 2023 was projected to reach 944 million tonnes, marking a 0.9% increase over 2022, indicating a growing need for animal-based foods as income levels rise and dietary preferences shift towards protein. Consequently, the expanding livestock population is set to boost the foot and mouth disease vaccine market. Rising healthcare spending is anticipated to boost the foot and mouth disease vaccine market’s expansion in the future. This spending represents the overall financial outlay on healthcare products and services during a defined period. Such expenditure aids research and development initiatives within veterinary medicine, helping to create more potent and sophisticated vaccines, specifically those designed to prevent foot and mouth disease in animals. For instance, the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, reported in November 2025 that healthcare systems in member nations allocated an average of 9.3% of their GDP to health in 2024, indicating renewed growth in real per capita spending following stagnation in 2023, with average spending per individual returning to over 3% annual growth. Thus, the rise in healthcare expenditure is stimulating the growth of the foot and mouth disease vaccine market.

What Major Segment Divisions Exist Within The Anthrax Vaccine Market?

The foot and mouth disease vaccine market covered in this report is segmented –

1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines

2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals

3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels

Subsegments:

1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines

2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines

3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines

4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines

How Are Trends Shaping The Direction Of The Foot And Mouth Disease Vaccine Market?

Key companies operating within the foot and mouth disease vaccine market are developing innovative offerings, such as clinical phases, to enhance their market profitability. Clinical trials are research endeavors that assess new treatments and medications. For example, in June 2023, The Department of Animal Husbandry and Dairying, an India-based ministry, launched the 3rd Phase of FMD Vaccination under NADCP. This third phase of the NADCP’s FMD vaccination program represents a thorough endeavor to combat FMD in cattle and is an integral part of a larger strategy to manage FMD through vaccination by 2025 and ultimately eradicate it by 2030. This project is vital for improving local output and expanding the exports of milk and animal products.

Which Companies Are Leading Innovation In The Anthrax Vaccine Market?

Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Merck & Co. Inc., Intervet India Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, Alivira Animal Health Limited, Zoetis Inc., Dong Bang Co. Ltd., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Biovet Private Limited, MEVAC, SPIC Gene Science Technology Development Co. Ltd., VETAL Animal Health Products Inc., Southern Cross Group, VECOL S.A, Limor de Colombia

Read the full foot and mouth disease vaccine market report here:

https://www.thebusinessresearchcompany.com/report/foot-and-mouth-disease-vaccine-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Anthrax Vaccine Market?

Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2025. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anthrax Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8522&type=smp

Browse Through More Reports Similar to the Global Foot And Mouth Disease Vaccine Market 2026, By The Business Research Company

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Respiratory Disease Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report

Therapeutic Bcg Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795